Are there any Therapeutic Options Currently Available for Wuhan Coronavirus?
Author:
Affiliation:
1. Department of Pharmacy “G. d’Annunzio” University of Chieti-Pescara Via dei Vestini 31, 66100, Chieti, Italy
Abstract
Publisher
Bentham Science Publishers Ltd.
Subject
Pharmacology,General Medicine,Immunology,Immunology and Allergy
Reference8 articles.
1. Yu F.; Du L.; Ojcius D.M.; Pan C.; Jiang S.; Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China. Microb Infect 2020,22(2),74-79
2. Chen J.; Pathogenicity and transmissibility of 2019-nCoV-A quick overview and comparison with other emerging viruses. microbes and infection Microb Infect 2020,22(2),69-71
3. Lu R.; Zhao X.; Li J.; Niu P.; Yang B.; Wu H.; Wang W.; Song H.; Huang B.; Zhu N.; Bi Y.; Ma X.; Zhan F.; Wang L.; Hu T.; Zhou H.; Hu Z.; Zhou W.; Zhao L.; Chen J.; Meng Y.; Wang J.; Lin Y.; Yuan J.; Xie Z.; Ma J.; Liu W.J.; Wang D.; Xu W.; Holmes E.C.; Gao G.F.; Wu G.; Chen W.; Shi W.; Tan W.; Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 2020,395(10224),565-574
4. Costante R.; Stefanucci A.; Carradori S.; Novellino E.; Mollica A.; DPP-4 inhibitors: a patent review (2012 - 2014). Expert Opin Ther Pat 2015,25(2),209-236
5. Wang M.; Cao R.; Zhang L.; Yang X.; Liu J.; Xu M.; Shi Z.; Hu Z.; Zhong W.; Xiao G.; Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res 2020,30(3),269-271
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Exploring the Efficacy of Shirodhara as an Add-on Therapy for Alleviating Post-COVID Anxiety and Depression: A Case Study;2024-02-27
2. Post-COVID-19 Syndrome Clinical Manifestations: A Systematic Review;Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry;2022-06
3. The Chronicle of COVID-19 and Possible Strategies to Curb the Pandemic;Current Medicinal Chemistry;2021-05-31
4. Natural Products Database Screening for the Discovery of Naturally Occurring SARS‐Cov‐2 Spike Glycoprotein Blockers;ChemistrySelect;2020-11-13
5. Resolution of coronavirus disease 2019 (COVID-19);Expert Review of Anti-infective Therapy;2020-08-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3